Insider activity raises questions: Executives at ASP Isotopes have sold over $2.5 million in shares amid the stock hovering near its 52-week low, even as the company projects a $300 million EBITDA target. This development has prompted market observers to scrutinize the alignment between leadership actions and long-term ambitions.
Catalyst timeline draws attention: Discussions highlight the impending restart of enrichment facilities in the third quarter, with initial high-purity Silicon-28 deliveries slated for key semiconductor clients. Traders note that recent price weakness stems from a temporary revenue gap, yet structural shifts toward commercial operations could alter the trajectory.
Helium supply dynamics in focus: Broader conversations link potential helium shortages from geopolitical tensions to opportunities for the company, given its positioning in related isotope production. Market participants emphasize that sustained institutional interest and secured contracts may provide underlying support despite short-term volatility.
Note: This discussion summary was generated from an AI condensation of post data.
ASP Isotopes Insider Trading Activity
ASP Isotopes insiders have traded $ASPI stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $ASPI stock by insiders over the last 6 months:
- PAUL ELLIOT MANN (Chairman and CEO) has made 0 purchases and 4 sales selling 413,428 shares for an estimated $2,885,800.
- TODD WIDER has made 0 purchases and 2 sales selling 100,000 shares for an estimated $618,500.
- DONALD GEORGE AINSCOW (EVP, Gen Counsel, Secretary) sold 100,000 shares for an estimated $614,000
- ROBERT AINSCOW (COO) has made 0 purchases and 4 sales selling 64,376 shares for an estimated $334,839.
- HEATHER KIESSLING (Chief Financial Officer) has made 0 purchases and 2 sales selling 46,248 shares for an estimated $271,891.
- MICHAEL GORLEY sold 30,000 shares for an estimated $188,100
- DUNCAN MOORE sold 11,642 shares for an estimated $60,596
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ASP Isotopes Hedge Fund Activity
We have seen 103 institutional investors add shares of ASP Isotopes stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ENCOMPASS CAPITAL ADVISORS LLC added 6,912,054 shares (+inf%) to their portfolio in Q1 2026, for an estimated $30,551,278
- ALYESKA INVESTMENT GROUP, L.P. removed 2,203,380 shares (-45.0%) from their portfolio in Q1 2026, for an estimated $9,738,939
- BLACKROCK, INC. added 1,538,727 shares (+22.7%) to their portfolio in Q1 2026, for an estimated $6,801,173
- GOLDMAN SACHS GROUP INC removed 1,188,497 shares (-69.3%) from their portfolio in Q1 2026, for an estimated $5,253,156
- CITADEL ADVISORS LLC removed 957,547 shares (-55.5%) from their portfolio in Q1 2026, for an estimated $4,232,357
- JANE STREET GROUP, LLC removed 902,482 shares (-56.9%) from their portfolio in Q1 2026, for an estimated $3,988,970
- TELEMARK ASSET MANAGEMENT, LLC removed 825,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,646,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
